“Big BioPharma needs growth,” says Wells Fargo analyst Mohit Bansal in a research note that anticipates a pick-up in smaller deals in the sector.
“Big BioPharma needs growth,” says Wells Fargo analyst Mohit Bansal in a research note that anticipates a pick-up in smaller deals in the sector.